An antineoplastic agent used to treat ovarian cancer. It works by inhibiting DNA topoisomerases, type I.
用于小细胞肺癌(SCLC)和一线治疗失败的晚期转移性卵巢癌。
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.